Prevention of infection due to Pneumocystis carinii

被引：83
作者：
Fishman, JA
机构：
[1] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 05期
关键词：
D O I：
10.1128/AAC.42.5.995
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：995 / 1004
页数：10
相关论文
共 144 条
  • [1] [Anonymous], 1997, MMWR Recomm Rep, V46, P1
  • [2] AEROSOLIZED PENTAMIDINE, COTRIMOXAZOLE AND DAPSONE PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMIC ENCEPHALITIS
    ANTINORI, A
    MURRI, R
    AMMASSARI, A
    DELUCA, A
    LANZALONE, A
    CINGOLANI, A
    DAMIANO, F
    MAIURO, G
    VECCHIET, J
    SCOPPETTUOLO, G
    TAMBURRINI, E
    ORTONA, L
    [J]. AIDS, 1995, 9 (12) : 1343 - 1350
  • [3] Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients
    Arend, SM
    Westendorp, RGJ
    Kroon, FP
    vantWout, JW
    Vandenbroucke, JP
    vanEs, LA
    vanderWoude, FJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) : 920 - 925
  • [4] SYNTHESIS, STABILITY, AND BIOLOGICAL EVALUATION OF WATER-SOLUBLE PRODRUGS OF A NEW ECHINOCANDIN LIPOPEPTIDE - DISCOVERY OF A POTENTIAL CLINICAL AGENT FOR THE TREATMENT OF SYSTEMIC CANDIDIASIS AND PNEUMOCYSTIS-CARINII PNEUMONIA (PCP)
    BALKOVEC, JM
    BLACK, RM
    HAMMOND, ML
    HECK, JV
    ZAMBIAS, RA
    ABRUZZO, G
    BARTIZAL, K
    KROPP, H
    TRAINOR, C
    SCHWARTZ, RE
    MCFADDEN, DC
    NOLLSTADT, KH
    PITTARELLI, LA
    POWLES, MA
    SCHMATZ, DM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) : 194 - 198
  • [5] Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia
    Barber, BA
    Pegram, PS
    High, KP
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 718 - 722
  • [6] INFECTIONS IN HUMAN LIVER RECIPIENTS - DIFFERENT PATTERNS EARLY AND LATE AFTER TRANSPLANTATION
    BARKHOLT, L
    ERICZON, BG
    TOLLEMAR, J
    MALMBORG, AS
    EHRNST, A
    WILCZEK, H
    ANDERSSON, J
    [J]. TRANSPLANT INTERNATIONAL, 1993, 6 (02) : 77 - 84
  • [7] NEW RAT MODEL OF PNEUMOCYSTIS-CARINII INFECTION
    BARTLETT, MS
    FISHMAN, JA
    QUEENER, SF
    DURKIN, MM
    JAY, MA
    SMITH, JW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (06) : 1100 - 1102
  • [8] EVALUATION OF POTENT INHIBITORS OF DIBYDROFOLATE REDUCTASE IN A CULTURE MODEL FOR GROWTH OF PNEUMOCYSTIS-CARINII
    BARTLETT, MS
    SHAW, M
    NAVARAN, P
    SMITH, JW
    QUEENER, SF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2436 - 2441
  • [9] PNEUMOCYSTIS-CARINII IS RESISTANT TO IMIDAZOLE ANTIFUNGAL AGENTS
    BARTLETT, MS
    QUEENER, SF
    SHAW, MM
    RICHARDSON, JD
    SMITH, JW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) : 1859 - 1861
  • [10] COMPARISON OF CORTICOSTEROID AND L3T4(+) ANTIBODY IMMUNOSUPPRESSED MOUSE MODELS OF PNEUMOCYSTIS-CARINII PNEUMONIA FOR EVALUATION OF DRUGS AND LEUKOCYTES
    BARTLETT, MS
    CURRENT, WL
    ORAZI, A
    BAUER, NL
    NEIMAN, RS
    QUEENER, SF
    SMITH, JW
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (05) : 511 - 516
12345678910